Rodolfo F Perini

Katya Frazier,Eric Muise, Joshua Stolz, Lukas Fischer, Mark Buchanan, Charlie Schneider, Brian Pak Ho Chan, Richard Carr,Rodolfo Perini,Brian Long,Douglas Linn

Cancer Immunology Researchno. 10_Supplement (2024)

Cited0Views0Bibtex

1695P Phase I LITESPARK-018: Dose Escalation Study of Belzutifan in Advanced Pretreated Clear Cell Renal Cell Carcinoma (Ccrcc)

U.N. Vaishampayan, A.J. Zurita Saavedra,K. Beckermann,A. Chain,D. Vickery, Y. Zhang,R. Perini,D.F. McDermott

Annals of Oncology (2024): S1016

Cited0Views0Bibtex

Supplementary Figure 2 from Belzutifan for Von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study

Tobias Else,Eric Jonasch,Othon Iliopoulos,Kathryn E. Beckermann,Vivek Narayan,Benjamin L. Maughan,Stephane Oudard,Jodi K. Maranchie,Ane B. Iversen,Cynthia M. Goldberg, Wei Fu,Rodolfo F. Perini,Yanfang Liu,W. Marston Linehan,Ramaprasad Srinivasan

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Senior Principal Scientist

Papers共 219 篇Author StatisticsCo-AuthorSimilar Experts